CRYSTALLINE FORMS OF A MAGL INHIBITOR

Described herein are new crystalline forms of the MAGL inhibitor 1-(1-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)b enzyl)-1,8-diazaspiro[4.5]decane-8-carbonyl)-1H-pyrazole-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.

Saved in:
Bibliographic Details
Main Authors ANDREW, Samuel George, EDWARDS, Richard James, GRICE, Cheryl A, JUHL, Martin, BUZARD, Daniel J, VETTER, Thomas, LOPEZ DE DIEGO, HEIDI, WIENER, John J.M, PATTERSON, Adam Ross, ALLAN, Amy, DEL RIO GANCEDO, Susana, CINCOTTI, Antonio
Format Patent
LanguageEnglish
Published 24.08.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Described herein are new crystalline forms of the MAGL inhibitor 1-(1-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)b enzyl)-1,8-diazaspiro[4.5]decane-8-carbonyl)-1H-pyrazole-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.
Bibliography:Application Number: US202218051654